Skip to content

Clinical trials

Phase 2 Colitis, Ulcerative trials in India

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colitis, Ulcerative Phase: Phase 2 Country / region: India Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20181
20192
20212
20223
20231
20241
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting4
Terminated4
Active, not recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Janssen Research & Development, LLC2
Sanofi2
AstraZeneca1
Cerimon Pharmaceuticals1
Genentech, Inc.1
GlaxoSmithKline1
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)1
Nektar Therapeutics1
Oppilan Pharma Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colitis, Ulcerative16
Inflammatory Bowel Diseases3
Colitis1
Lymphoma, Follicular1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.